Chronic exposure to styrene and a number of other volatile organic compounds has been linked to the occurrence of neurologic and behavioral deficits, including increased reaction time ([@b32-ehp0113-000532]), visual system disturbances ([@b28-ehp0113-000532]), and neurophysiologic alterations (e.g., [@b24-ehp0113-000532]; [@b35-ehp0113-000532]; [@b49-ehp0113-000532]; [@b51-ehp0113-000532]). In addition, a number of dosimetric studies have quantified the relationship between inhaled styrene and markers of exposure: urinary concentrations of styrene ([@b16-ehp0113-000532]; [@b19-ehp0113-000532]; [@b26-ehp0113-000532], [@b27-ehp0113-000532]; [@b45-ehp0113-000532]) or mandelic acid, its major excretory metabolite ([@b6-ehp0113-000532]; [@b9-ehp0113-000532]; [@b12-ehp0113-000532]; [@b50-ehp0113-000532]). The findings in this literature suggest that styrene may exert a variety of effects on the nervous system and that sufficient dosimetric information exists to develop quantitative relationships between these effects and conditions of exposure. The purpose of this study was to perform a meta-analysis of these observations, to quantify the relationship between exposure (estimated from the biomarkers) and effects on two measures of central nervous system function: reaction time and color vision. An effort was made to assess the importance of styrene-related deficits to real-world task performance. An insufficient number of reports were found for meta-analyses of other neurotoxic effects.

Behavioral Outcomes
===================

Reaction time has been a popular variable for assessment of impaired behavioral task performance for several reasons, including ease of measurement, adversity of effect, and sensitivity to drugs and toxic chemicals. Reaction time tasks are usually divided into simple reaction time (SRT), in which the subject must simply react to a predefined stimulus as quickly as possible, and choice reaction time (CRT), in which the subject must first select between options before deciding whether or in what way to respond.

Long-term exposure to a number of solvents has been reported to also produce deficits in the performance of screening tests for perception of color or visual contrast ([@b15-ehp0113-000532]; [@b28-ehp0113-000532]). Perhaps the most prevalent agent in this growing literature is styrene, for which numerous published studies have reported that exposure was associated with visual deficits, in particular, an acquired impairment of color perception. Color vision was usually assessed using the Lanthony desaturated D-15d color vision test ([@b34-ehp0113-000532]), a hue discrimination test designed to grade the loss of color discrimination from mild to moderate. Performance on the test was usually quantified using the color confusion index (CCI) scale ([@b14-ehp0113-000532]). Details of testing procedure and scoring are reviewed in [@b15-ehp0113-000532].

Meta-Analyses
=============

The literature reporting the effects of long-term styrene exposure on behavioral performance is diverse. Critical experimental factors such as group sizes, analytical approaches, and methodologic details vary greatly across studies. A meta-analysis of the literature involving a quantitative treatment of the combined data from a number of individual reports can help unify the literature by improving *a*) accuracy, by minimizing the impact of single, perhaps anomalous reports; *b*) precision, by including a large number of subjects; and *c*) generality, by aggregating a variety of studies with differing subject populations and exposure histories.

A meta-analysis of the effects of exposure to styrene and other organic solvents on CCI was recently reported by [@b44-ehp0113-000532]. This analysis featured means from various studies that were converted to *Z*-scores to place them on a common scale of measurement for comparison and to help assess the possibility that an effect might have been statistically significant. High variance was observed between the results of different studies after transformation, and the authors argued that no reliable conclusions could be drawn about the effects of styrene on CCI. The *Z*-score transform, however, compares the magnitude of each particular effect (the mean) with the variance for that measure. This transform conflates the measure of magnitude of an effect with its stability, so a transformed score may be larger or smaller depending on the variance of the group.

In the present work, our intent was to evaluate the magnitude of styrene effects on CCI and reaction times. Thus, values were not converted to *Z*-scores but were expressed as a percentage of baseline. The dose levels were expressed as inhaled-air styrene concentration multiplied by the work-years of exposure. These data were then fitted to a dose--effect regression equation. In this analysis, magnitude estimates were not conflated with variances, and the variation among the reported data was used to compute confidence limits and test the fitted result for statistical significance ([@b3-ehp0113-000532]).

Materials and Methods
=====================

Estimates of Exposure
---------------------

In the neurobehavioral reports, four different measures were used to quantify the level of exposure to styrene: *a*) concentration of styrene in inhaled air (personal monitors) given as a time-weighted average (TWA), *b*) concentration of styrene in urine, *c*) concentration of mandelic acid in urine as a fraction of creatinine in urine, and *d*) concentration of mandelic acid in urine. Individual-subject data were given via scatter plots in some studies, whereas only group means were provided in others. In the interest of homogeneity, we computed group means from individual-subject data and used them to express inhaled-air styrene concentration. We also analyzed individual-subject exposure concentrations as a check on the results obtained from means.

To pool the data on effects of exposure across studies, it was necessary to convert data from the reported measurement of exposure to one common scale (inhaled-air styrene concentration). To estimate inhaled-air styrene concentration from the measures supplied by the original authors, we found representative publications in which the various methods of reporting urinalyses were standardized and tested ([Table 1](#t1-ehp0113-000532){ref-type="table"}). In these publications, styrene measurements from personal monitors were recorded for a work shift, and then urine was sampled after exposure. We digitized plotted data for individual subjects and pooled them into common databases, one for each of the three methods of urine analysis. We then fitted regression equations to the pooled data to predict inhaled-air styrene concentration from the various observed urine measures.

In neurobehavioral studies, exposure to styrene was usually estimated at the end of a work shift. It was implicitly assumed by the authors of the reviewed articles that this single measure was a representative measure of the workers' exposure history. This measure of exposure would underestimate historical exposure in cases where there have been improvements in environmental controls in the workplace ([@b20-ehp0113-000532]).

Duration of exposure in work-years was given in all of the neurobehavioral reports, but always as group means, even when individual-subject data were given for styrene concentration. The mean duration of exposure and mean concentration, although fixed for a particular report, varied across reports. Thus, when pooling data from several reports, we were able to analyze for the effects of a combination of concentration and duration of exposure, expressed as the product of concentration and time (ppm work-years) ([@b7-ehp0113-000532]; [@b23-ehp0113-000532]; [@b39-ehp0113-000532]).

Measures of Adverse Outcomes
----------------------------

In each neurobehavioral study, tests were given at a fixed time after the last exposure, usually the morning after the work shift of the previous day; occasionally a weekend elapsed between the last exposure and behavioral testing. This delay was intended to avoid possible acute effects of the parent compound or its metabolites.

Most of the reports did not specify whether the personnel administering the tests were aware of the group to which each subject belonged ([Tables 2](#t2-ehp0113-000532){ref-type="table"}, [3](#t3-ehp0113-000532){ref-type="table"}). Such "nonblind" procedures have the potential to overestimate the effects of a toxicant in laboratory experiments ([@b2-ehp0113-000532]).

Four publications produced a total of seven data points for CRT ([Table 2](#t2-ehp0113-000532){ref-type="table"}). For SRT, three articles yielded six data points ([Table 3](#t3-ehp0113-000532){ref-type="table"}). Some studies provided data on both SRT and CRT. Only those studies of color vision that employed the Lanthony desaturated D-15d test were used ([Table 4](#t4-ehp0113-000532){ref-type="table"}). The data were individual CCI and styrene exposure estimates from five studies. The illuminants used in testing were of intensity 1,000--1,200 lux with spectral distribution specified as "daylight illumination." Color vision testing was done in the morning, before the work shift in four of five of the references used. CCI was reported as a raw score in three of the five studies; in the other two, CCI was adjusted for individual age and alcohol consumption. In the three studies reporting raw CCI scores, subjects were eliminated from analyses if criteria were exceeded for age, disease, alcohol consumption, or drug use.

Quantitative Procedures
-----------------------

When data were graphically presented in publications, graphs were digitized as previously described ([@b3-ehp0113-000532]). Graphs were scanned and imported into digitization software (UN-SCAN-IT; Silk Scientific, Orem, UT), which produced a table of *x,y*-coordinates for each data point. Because some of the points on a plot were hidden behind others, the number of digitized data points was always slightly less than the number of points that the original authors reported. The number of digitized points was used and reported in the present work. When data were given numerically by the authors, these were used directly.

### Normalization of data before pooling.

Data from different studies can be pooled only if the measurement scales can be made comparable. Each datum was adjusted as follows:
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in which *E* is a normalized (effect) value, *D* is the value of the unadjusted dependent variable, and *B* is the value of a baseline condition. In studies where only means were reported, the performance of the control group provided baseline values. In some other studies reporting individual-subject data, independent control groups were not studied, and the investigators relied on a dose--effect analysis in which subjects with very low exposures served as implicit controls. In the present work, when individual-subject data were given, the mean of all data from exposed to \< 10 ppm styrene was used as a baseline. This procedure was followed even if specific control groups were measured to assure consistency and also to include the maximum number of studies in the meta-analysis.

### Fitting dose--effect curves.

The data were pooled after all useable data had been transformed by Equation 1 and all exposure data had been converted to inhaled-air styrene. A linear regression equation of the form
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was then fitted to the data. Here *Ē* is the estimated value of the effect, *C* is the concentration of styrene in inhaled air (parts per million), *t* is the duration of exposure (work-years), and the βs are empirical parameters fitted with a least-squares procedure (Proc REG; SAS Institute Inc., Cary, NC). Equation 2 was fitted first to assure that the intercept term, β~1~, was near zero and not statistically significant (which should be the case for data adjusted by Equation 1). If the intercept term was not statistically significant, Equation 2 was refitted with only a slope (β~2~) term.

In cases where the regression lines were fitted to means from various studies or groups, each mean was weighted by the number of subjects for that mean. This was done by the "weight" statement of Proc REG. This had the effect of giving the larger studies (with smaller SEs) greater weight in the fitting procedure. If a regression equation was found to be statistically significant, the data were plotted with the effect on the y-axis and with the product of styrene concentration (in parts per million) and work-years on the x-axis. In general, when regression lines are fitted to means instead of individual-subject data, estimated lines are very nearly the same, but confidence limits will be somewhat wider than if individual-subject data had been available. This may be intuitively explained as due to the loss of information when means are used. The effects were also plotted separately as functions of styrene parts per million alone with four lines for 2, 4, 6, and 8 work-years of exposure. These lines were calculated by solving the regression equation with styrene concentration as the independent variable for each of the work-years of exposure (either 2, 4, 6, or 8). Because some of the published reports gave SRT and CRT data only as means ± SDs, all regression lines were fitted to means, even for CCI, where individual-subject data were available. For the CCI data, means were computed from the baseline-adjusted individual-subject data by dividing the exposure range of each report into two or three subranges and computing the means of exposure and effect magnitude within the subranges. To assess the effect of converting individual-subject data to means, a regression line was also fitted to the individual-subject data.

Results
=======

Estimating Exposure
-------------------

We evaluated the relationship between styrene concentration in inhaled air and styrene concentration in urine from the pooled individual-subject data from five reports ([Table 1](#t1-ehp0113-000532){ref-type="table"}). These data are presented in [Figure 1](#f1-ehp0113-000532){ref-type="fig"} along with a linear regression line and 95% confidence limits (CLs). We evaluated the relationship between inhaled-air styrene concentration and mandelic acid in urine (expressed as milligrams per gram creatinine) from the pooled data of three studies ([Table 1](#t1-ehp0113-000532){ref-type="table"}) and the result is given in [Figure 2](#f2-ehp0113-000532){ref-type="fig"}. Results from the only study ([@b12-ehp0113-000532]) that estimated inhaled-air styrene concentration from mandelic acid (expressed in grams per liter) are shown in [Figure 3](#f3-ehp0113-000532){ref-type="fig"}. Parameters and statistical tests for the three regression lines are given in [Table 5](#t5-ehp0113-000532){ref-type="table"}. All of the relationships were statistically significant.

Effects of Styrene on Neurobehavioral Measures
----------------------------------------------

### Reaction time.

In one case, [@b40-ehp0113-000532] found that urine samples were collected in the morning, just before behavioral testing; in all other cases, urine samples were taken at the end of a work shift. The data for exposures for [@b40-ehp0113-000532] were back adjusted to an end-of-shift value, using a published elimination curve ([@b11-ehp0113-000532], their [Figure 1](#f1-ehp0113-000532){ref-type="fig"}, group I).

We fitted equation 2 to the pooled mean data for CRT (seven observations) from the studies in [Table 2](#t2-ehp0113-000532){ref-type="table"}. We observed a statistically significant linear relationship between the mean proportional increase in CRT and cumulative styrene exposure. The intercept term was not statistically significant, and the no-intercept fitted equation was statistically significant, accounting for 91% of the variance ([Table 6](#t6-ehp0113-000532){ref-type="table"}). The mean data along with the fitted equation and 95% CLs are plotted in [Figure 4](#f4-ehp0113-000532){ref-type="fig"}. The size of the plotted points reflects the relative number of subjects used in computing each mean. Because one of the means in the CRT data was collected at considerably higher exposure (1,336 ppm work-years) and therefore had a much greater effect magnitude ([Figure 4](#f4-ehp0113-000532){ref-type="fig"}), concern arose that the fitted line may have been heavily influenced by this point. We did an exploratory analysis without the extreme point, and the results are given in [Table 6](#t6-ehp0113-000532){ref-type="table"} (labeled "CRT, exploratory"). [Figure 5](#f5-ehp0113-000532){ref-type="fig"} gives the effect magnitude as a function of styrene parts per million for 2, 4, 6, and 8 work-years of exposure (calculated by setting the work-years of exposure to either 2, 4, 6 or 8, and solving for the effect of parts per million with the fitted regression equation).

The relationship between SRT and styrene exposure was not statistically significant in the pooled mean data from three studies ([Table 6](#t6-ehp0113-000532){ref-type="table"}).

### Color confusion index.

We fitted a regression equation to mean data (as computed from the individual-subject data) to keep the CCI results comparable with those of reaction time. The intercept term was not statistically significant, and the no-intercept form of the equation was statistically significant and accounted for 35% of the variance ([Table 6](#t6-ehp0113-000532){ref-type="table"}). [Figure 6](#f6-ehp0113-000532){ref-type="fig"} is a plot of the mean data along with the fitted line and its 95% CLs. The size of the plotted points reflects the relative number of subjects used in computing each mean. Equation 2 was also fitted to the pooled individual-subject data (329 observations) from the studies in [Table 3](#t3-ehp0113-000532){ref-type="table"}. The intercept term was not statistically significant and the no-intercept form was statistically significant with the β~2~ term similar to that for the equation fitted to the means ([Table 6](#t6-ehp0113-000532){ref-type="table"}). [Figure 7](#f7-ehp0113-000532){ref-type="fig"} is a plot of the individual-subject data and the fitted line with 95% CLs. The confidence limit for individual-subject data is somewhat narrower than for the means ([Figure 6](#f6-ehp0113-000532){ref-type="fig"}). The scale of [Figure 7](#f7-ehp0113-000532){ref-type="fig"} was kept the same as [Figure 6](#f6-ehp0113-000532){ref-type="fig"} to facilitate comparisons, even though some of the points were off scale.

[Figure 8](#f8-ehp0113-000532){ref-type="fig"} gives the magnitude of effect plotted as a function of styrene ppm for 2, 4, 6, and 8 work-years of exposure (calculated by setting the work-years of exposure to either 2, 4, 6, or 8 and solving for the effect of parts per million with the fitted regression equation). The scales were kept the same as for [Figure 5](#f5-ehp0113-000532){ref-type="fig"} to facilitate comparison with CRT results.

Discussion
==========

Estimates of Exposure
---------------------

Inhaled-air styrene concentration was linearly related to styrene concentration or its metabolites in urine ([Figures 1](#f1-ehp0113-000532){ref-type="fig"}--[3](#f3-ehp0113-000532){ref-type="fig"}). Inspection of these figures reveals that, although the equations fit well, a number of individual-subject data lay outside the confidence limits. One potential source of such errors is the measurement of inhaled-air styrene, which was usually made with dosimeters placed "near" the subject's personal exposure space and might not have measured actual exposure. Another potential source of variance involves differences in physical activity across subjects, which would have affected the amount of styrene inhaled. Despite the observed variability, the overall trend and the statistical significance of the fitted lines in [Figures 1](#f1-ehp0113-000532){ref-type="fig"}--[3](#f3-ehp0113-000532){ref-type="fig"} reveal that all three biomarkers of styrene exposure provide reasonable indicators of recent exposure.

Behavioral Effects
------------------

### Choice reaction time.

Cumulative styrene was associated with increased CRT in a dose-related manner. Inspection of [Figure 4](#f4-ehp0113-000532){ref-type="fig"} reveals that one point lies at a higher exposure value with respect to the others. That point is the mean for one of four groups from the same study, each exposed to a different amount of styrene. These four means are represented as the smallest four points in [Figure 4](#f4-ehp0113-000532){ref-type="fig"}. They form a series that is consistent with the fitted dose effect function. Each of the points is the mean of 18--28 subjects, for a total of 100 subjects. Despite the fact that one point is outstanding in [Figure 4](#f4-ehp0113-000532){ref-type="fig"}, the fact that it came from the only study with multiple exposure levels makes the resulting fitted equation plausible. Furthermore, an exploratory analysis, with the extreme point removed from the data set, yielded only a slightly lower slope and a poorer fit. The fitted line from the exploratory analysis was well within the confidence limits of the line fitted to the whole data set. More data at the upper end of exposure would improve the confidence limits.

No significant effects were observed on SRT, perhaps because the largest exposure for the SRT data was only about 250 ppm work-years. Thus, there may not have been sufficient exposure to produce a reliably detectable effect.

Under the assumption that the metric of exposure can be separated into discrete concentration (parts per million) and duration (work-years) components, the lines in [Figure 5](#f5-ehp0113-000532){ref-type="fig"} may be used to estimate the magnitude of various exposure histories on CRT. For example, 8 work-years at 150 ppm is estimated to produce an increase in CRT of almost 50%. For 20 ppm, a contemporary limit for occupational styrene exposure \[[@b1-ehp0113-000532]\] for 8 work-years is estimated to produce a 6.5% increase in CRT. By use of the fitted dose--effect equation the increase in CRT can be estimated for any combination of concentration and duration of exposure.

### Importance of rapid reaction times.

The importance of reaction times has been discussed in a number of ergonomic settings, among which perhaps the most quantitative is automobile driving. For drivers in the United States, it has been estimated that reducing the reaction time by 100 msec would reduce accident-related property damage costs alone by \$655,000,000 annually (1994 US\$) and prevent 58,000--70,000 injuries per year ([@b4-ehp0113-000532]; [@b30-ehp0113-000532]). For unexpected events, a decrease in reaction time of 100 msec is about 7% of the normal reaction time, and for expected events 100 msec is about 14% ([@b21-ehp0113-000532]). Thus, changing reaction time by 7--14% has important economic and personal implications. Styrene exposure to permissible levels produced the magnitude of change upon which the above economic estimates were based. In addition, consideration should be given to the possibility that people sometimes have additionally increased reaction times due to work-related fatigue and consumption of ethanol and drugs.

Given the above information it would be possible to calculate the benefit of any proposed changes in styrene exposure limits if data were available on *a*) the number of workers exposed to styrene, *b*) the distribution of exposure concentrations and durations, and *c*) the duration of the effect after cessation of work-place exposures. It would then be possible to compare the cost of regulation to the benefit of such regulation on a continuous dose-related scale. Presumably, the above data could be found, except for estimates of the permanence of the increased CRT after exposure cessation.

### Color vision.

Long-term exposure to styrene was associated with increased errors in performing a color discrimination/arrangement task in the pooled data from six studies of occupationally exposed workers. The mean effect size for CCI was estimated with closer confidence limits for [Figure 7](#f7-ehp0113-000532){ref-type="fig"} than for [Figure 6](#f6-ehp0113-000532){ref-type="fig"} because of the use of individual-subject data, but the regression lines for the two procedures were similar. The individual-subject observations scattered widely about the estimated line, lowering the variance accounted for. For an exposure of 8 work-years to 150 ppm, the estimated increase in CCI score was approximately 17% ([Figure 8](#f8-ehp0113-000532){ref-type="fig"}). This is lower than for CRT, which was estimated at nearly 50%. For 20 ppm, a typical limit ([@b1-ehp0113-000532]) for 8 work-years, there was an estimated 2.23% increase in CCI.

Color vision deficiencies associated with exposure to styrene and other solvents have been associated primarily with difficulty in discriminating among colors at the "blue" end of the spectrum. This is commonly referred to as a blue/yellow deficit. This type of color vision deficit could be associated with reduced function in the short-wavelength-sensitive (blue) cones or their associated ganglion cells ([@b22-ehp0113-000532]; [@b25-ehp0113-000532]; [@b43-ehp0113-000532]). Why, or if, these cones are actually more susceptible is not well understood.

The measures of CCI show a relatively large variance among individual subjects, as was observed in group mean data by [@b44-ehp0113-000532]. Factors that could contribute to this variance include use of incorrect chromaticity values derived from the saturated Farnsworth-Munsell D-15 test, rather than unsaturated D-15d test ([@b14-ehp0113-000532]; [@b15-ehp0113-000532]) and differences between spectrum color profiles of light sources labeled as "daylight" ([@b56-ehp0113-000532]). Also important are the effects of luminance and practice that were not necessarily constant across studies.

### Importance of color-vision deficits.

The importance of impaired color perception is difficult to specify quantitatively. The broad scope of tasks deleteriously affected by color confusion should, by itself, give weight to the importance of deficits. Color information is important to persons who are driving; making distance judgments; reading colored text on video monitors, medicine bottles, food cans, and the like; scanning for objects in a complex visual scene; or working with color-coded electrical circuitry ([@b33-ehp0113-000532]; [@b37-ehp0113-000532]; [@b42-ehp0113-000532]; [@b47-ehp0113-000532], [@b48-ehp0113-000532], [@b46-ehp0113-000532]). Congenital color deficiencies are related to poorer school performance, slowed CRT at traffic lights, difficulty with information processing from color video monitors, and increased difficulty with color-coded tasks ([@b8-ehp0113-000532]; [@b36-ehp0113-000532]; [@b41-ehp0113-000532]; [@b52-ehp0113-000532]). Although all of these tasks are important, there is no obvious way of relating these reported deficits to the magnitude of effects reported for styrene. For such a relationship to be established, experimental evidence is needed to relate CCI values to task performance.

It is possible to compare the effect of styrene exposure with the effect of aging on CCI. The CCI of men increases with age at the rate of about 10% of baseline every 13 years of age ([@b28-ehp0113-000532], their [Figure 1](#f1-ehp0113-000532){ref-type="fig"} and [Table 6](#t6-ehp0113-000532){ref-type="table"}). Thus, the deficit in color perception caused by exposures to styrene of 115 ppm for 8 work-years or 156 ppm for 6 work-years is roughly equivalent to 13 years of additional age in visual dysfunction. Eight work-years at 20 ppm (the ACGIH limit) would produce a 2.23% deficit, which is roughly equivalent to 1.7 additional years of age.

Reversibility of Effects
------------------------

It is not clear whether the effects of long-term styrene exposure are reversible. All of the data analyzed in the present work were collected at least 15 hr after the last exposure and therefore are probably not due to the concurrent presence of styrene or its metabolites in the blood. Some experimenters gave behavioral tests to subjects both before and after a day's exposure and found no statistically significant differences for CRT ([@b29-ehp0113-000532]; [@b53-ehp0113-000532]) or for CCI ([@b54-ehp0113-000532]). This implies that the acute body burden of styrene and its metabolites was not responsible for the effects and that longer-term processes were acting.

A few of the experimenters tested subjects both before and long times after exposure, to characterize the reversibility of effects. For CCI, [@b54-ehp0113-000532] reported that effects were reversible after 4 weeks of vacation. This study had relatively low exposures (even though the effect was large). [@b38-ehp0113-000532] reported that reduction of exposure due to workplace improvements also reduced the CCI effect (and other behavioral effects) after a period of 2 years. These data are scant and spotty but suggest the possibility that at least some recovery may occur from the effects of long-term exposure to styrene.

Possibility of Estimation Errors
--------------------------------

It is possible that the concentration of styrene in the past was greater, by an unknown amount, than indicated by contemporary measures because workplace improvements may have been made ([@b20-ehp0113-000532]). If this were the case, then the noted effects would have been due, in part, to higher styrene exposures in the past and not to the possibly lower concurrent exposures. Although this would have the effect of overestimating the magnitude of effect for any indicated concentration of exposure, it would not have affected the statistical significance of the finding that styrene produces the indicated effect.

On the other hand, all of the available data in this analysis were from studies of occupationally exposed workers. The risks of chronic styrene exposure to the general population may have been underestimated to the extent that healthy workers are not representative of the general population. It is possible that persons who are more susceptible to effects of styrene exposure do not remain in positions where such exposure occurs---the so-called "healthy-worker effect." It is also possible that nonworking persons such as the young or elderly might be more susceptible to effects of styrene exposure than are healthy workers.

Summary and Conclusions
=======================

Workplace styrene exposure can increase CRT and CCI. The magnitudes of the effects are statistically significant linear functions of parts per million work-years. The magnitude of each effect is a continuous function and reaches socially important values at realistic exposure concentrations.

Increased CRTs are associated with impairment of tasks performance, such as driving, that can be monetized for benefit--cost analysis. Increased color vision deficiencies are associated with difficulty in the performance of many everyday tasks. The cost of these increases is difficult to estimate. It appears that the effects on CRT and CCI persist for some time after exposure ends, but this conclusion is based on limited data.

The effects of styrene on CRT and CCI may have been overestimated by an unknown amount in this meta-analysis because of *a*) underestimates of past exposure and *b*) bias from experimenter knowledge of subject exposure status while testing. On the other hand, the potential for effects of styrene exposure in the general population may have been underestimated because of the healthy-worker phenomenon or because of the lack of susceptible persons in the workplace, such as the young or elderly.
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![Scatter plot and fitted regression line with 95% CLs for estimation of styrene concentration in inhaled air (TWA ppm) from mandelic acid in urine, normalized by creatinine (mg/g). Digitized individual-subject data were pooled from three studies.](ehp0113-000532f2){#f2-ehp0113-000532}
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![Scatter plot and fitted regression line with 95% CLs for estimation of effect of styrene exposure (ppm work-years) on CRT. Means from five studies were pooled after normalization as in Equation 1. The size of the plotted points indicates the relative number of subjects used in computing each mean.](ehp0113-000532f4){#f4-ehp0113-000532}
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![Scatter plot and fitted regression line with 95% CLs for estimation of effect of styrene exposure (ppm work-years) on CCI. Means were computed from digitized individual-subject data, which had been normalized by Equation 1. Means were then pooled from six studies. The size of the plotted points indicates the relative number of subjects in the computation of each mean.](ehp0113-000532f6){#f6-ehp0113-000532}
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###### 

Studies of styrene urinary measures as a function of styrene exposure.

  Reference               Urinary measure                   No.
  ----------------------- --------------------------------- -----
  [@b6-ehp0113-000532]    Mandelic acid (mg/g creatinine)   58
  [@b9-ehp0113-000532]    Mandelic acid (mg/g creatinine)   22
  [@b12-ehp0113-000532]   Mandelic acid (g/L urine)         44
  [@b16-ehp0113-000532]   Styrene                           88
  [@b19-ehp0113-000532]   Styrene                           193
  [@b26-ehp0113-000532]   Styrene                           92
  [@b27-ehp0113-000532]   Styrene                           25
  [@b45-ehp0113-000532]   Styrene                           93
  [@b50-ehp0113-000532]   Mandelic acid (mg/g creatinine)   66

###### 

Studies of styrene effects on CRT.

  Reference               Exposure measure                                                                                 CRT measure                                                                                    Control?   Blind?   No.   Comment
  ----------------------- ------------------------------------------------------------------------------------------------ ---------------------------------------------------------------------------------------------- ---------- -------- ----- ----------------------------------------------------------------------
  [@b29-ehp0113-000532]   MA in urine, end of shift (reference text)                                                       Preexposure (Table 2, "morning")                                                               Yes        ?        60    Means only
  [@b40-ehp0113-000532]   MA in urine, at behavior test time (reference text)                                              Preexposure (Table 2)                                                                          Yes        ?        100   Four independent means; exposure back calculated; see reference text
  [@b53-ehp0113-000532]   MA in urine, end of shift ([Table 3](#t3-ehp0113-000532){ref-type="table"} and reference text)   Preexposure, ([Table 4](#t4-ehp0113-000532){ref-type="table"}, CRT, group A)                   Yes        ?        56    Means only
  [@b55-ehp0113-000532]   Inhaled air concentration ([Table 1](#t1-ehp0113-000532){ref-type="table"})                      Preexposure, ([Table 4](#t4-ehp0113-000532){ref-type="table"}, mean of tests 2, 5, 6, and 8)   Yes        Yes      86    Means only

Abbreviations: ?, information not given in the referenced text; MA, mandelic acid. Figures, tables, and text listed in the table refer to source of data in reference cited.

###### 

Studies of styrene effects on SRT.

  Reference               Exposure measure                                                                                                              SRT measure                                                                    Control?   Blind?   No.   Comment
  ----------------------- ----------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------ ---------- -------- ----- ---------------------------------------------------------
  [@b13-ehp0113-000532]   Inhaled air concentration, ([Tables 1](#t1-ehp0113-000532){ref-type="table"} and [2](#t2-ehp0113-000532){ref-type="table"})   Preexposure, (Table 3, morning values)                                         Yes        ?        142   Four independent sites, one data point each; means only
  [@b29-ehp0113-000532]   MA in urine, end of shift (see reference text)                                                                                Preexposure ([Table 1](#t1-ehp0113-000532){ref-type="table"}, "morning")       Yes        ?        60    Means only
  [@b53-ehp0113-000532]   MA in urine, end of shift (Table 3 and reference text)                                                                        Preexposure, ([Table 4](#t4-ehp0113-000532){ref-type="table"}, SRT, group A)   Yes        ?        56    Means only

Abbreviations: ?, information not given in the referenced text; MA, mandelic acid. Figures, tables, and text listed in the table refer to source of data in reference cited.

###### 

Studies of styrene effects on CCI.

  Reference                                      Exposure measure                                                                                                              CCI measure                                                                                                        Control?   Blind?   No.   Comment
  ---------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------ ---------- -------- ----- -------------------------------------------------------------------------------
  [@b5-ehp0113-000532]                           Inhaled air, 2nd shift ([Table 1](#t1-ehp0113-000532){ref-type="table"})                                                      Preexposure ([Figure 1](#f1-ehp0113-000532){ref-type="fig"})                                                       No         ?        128   Raw data and means
  [@b10-ehp0113-000532]                          MA in urine, end of shift ([Table 1](#t1-ehp0113-000532){ref-type="table"})                                                   Preexposure ([Table 1](#t1-ehp0113-000532){ref-type="table"} and [Figure 3](#f3-ehp0113-000532){ref-type="fig"})   Yes        ?        62    Raw data and means
  [@b17-ehp0113-000532]; [@b18-ehp0113-000532]   Inhaled air, during shift \[[Table 1](#t1-ehp0113-000532){ref-type="table"} and reference text ([@b17-ehp0113-000532])\]      Preexposure \[[Figure 1](#f1-ehp0113-000532){ref-type="fig"} ([@b18-ehp0113-000532])\]                             Yes        Yes      51    Raw data and means in [@b18-ehp0113-000532]; details in [@b17-ehp0113-000532]
  [@b20-ehp0113-000532]                          MA in urine, end of shift ([Figure 2](#f2-ehp0113-000532){ref-type="fig"}, [Table 1](#t1-ehp0113-000532){ref-type="table"})   Preexposure ([Figure 3](#f3-ehp0113-000532){ref-type="fig"})                                                       Yes        Yes      55    Raw data and means
  [@b31-ehp0113-000532]                          MA in urine, end of shift ([Table 1](#t1-ehp0113-000532){ref-type="table"})                                                   Preexposure ([Table 2](#t2-ehp0113-000532){ref-type="table"} and [Figure 2](#f2-ehp0113-000532){ref-type="fig"})   Yes        ?        87    Raw data and means

Abbreviations: ?, information not given in the referenced text; MA, mandelic acid. Figures, tables, and text listed in the table refer to source of data in reference cited.

###### 

Statistics for exposure-estimation equations.

  Equation                                   *p*-Value   β~1~     β~2~      *R*^2^
  ------------------------------------------ ----------- -------- --------- --------
  Styrene concentration in urine             \< 0.0001   −1.749   0.6190    0.726
  Mandelic acid in urine (mg/g creatinine)   \< 0.0001   0.289    0.0793    0.838
  Mandelic acid in urine (g/L urine)         \< 0.0001   30.500   41.1000   0.851

The *p*-value is from the *F*-test for overall fit, the βs are the equation parameters, and *R*^2^ is the corrected value of squared correlation.

###### 

Statistics for dose--effect equations.

  Equation           *p*-Value   β~1~                                               β~2~                                               *R*^2^
  ------------------ ----------- -------------------------------------------------- -------------------------------------------------- --------------------------------------------------
  CRT                0.0002      −0.0209, *p* = 0.672                               0.000408, *p* = 0.0002                             0.909
  CRT, exploratory   0.0139      [---](#tfn5-ehp0113-000532){ref-type="table-fn"}   0.000327, *p* = 0.0139                             0.733
  SRT                0.5680      [---](#tfn5-ehp0113-000532){ref-type="table-fn"}   [---](#tfn5-ehp0113-000532){ref-type="table-fn"}   [---](#tfn5-ehp0113-000532){ref-type="table-fn"}
  CCI, means         0.0062      0.0344, *p* = 0.326                                0.000139, *p* = 0.0062                             0.348
  CCI, raw           \< 0.0001   0.0040, *p* = 0.821                                0.000184, *p* \< 0.0001                            0.072

---, parameter not statistically significant. The *p*-value is the *F*-test result for the final form of the fitted equation. The *p*-value for β~1~ is the *t*-test value for that parameter. If the β~1~ was not significant, the term was not included in the final form. The *p*-value for β~2~ is the *t*-test value for the final form. The *R*^2^ is the value for the final form.
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